FRAUD AND ABUSE IN SUBSTANCE USE TREATMENT

LEGAL UPDATE - OIG ADVISORY OPINION, MARCH 2, 2022
HHS OIG ISSUES FRAUD AND ABUSE ADVISORY OPINION ON CONTINGENCY
MANAGEMENT/PATIENT INCENTIVE PROGRAM
At long last, health care providers and suppliers seeking to use patient incentives for
contingency management to support evidenced based treatment for substance use disorder
patients have guidance on how to minimize risk of fraud and abuse. Advisory Opinion, Office
of Inspector General (OIG), posted March 2, 2022.
Background:
On March 2, 2022, Office of Inspector General for the Department of Health and Human
Services (OIG) issued Advisory Opinion No. 22-04 concluding that a digitally managed
substance use disorder treatment program offering direct incentives to patients presents a
low risk of fraud and abuse to Medicare and Medicaid. The OIG limited its favorable opinion
to the evidenced based and technology enabled program (the “CM Program”) operated
DynamicCare Health, Inc., a digital therapeutics company, on behalf of a broad group of feebased customers, including health plans, healthcare providers and employee assistance
programs.
The OIG warned providers and suppliers that cash and cash equivalent remuneration to
patients raises substantial risk of fraud and abuse, explaining that:

“[w]e have longstanding concerns relating to the offer of incentives intended to
induce beneficiaries to obtain federally reimbursable items and services, as such
incentives could present significant risks of fraud and abuse.”
In the Opinion, the OIG outlined the specific characteristics of a compliant contingency
management program for treatment of patients with substance use disorders.
Contingency Management Programs
Contingency management is a behavioral therapy that uses motivational incentives to
reinforce positive behaviors and tangible rewards to sustain treatment adherence. The
COVID-19 pandemic has exacerbated certain substance use disorders and limited treatment
options. Substance use disorder treatment providers have been haunted by the risks
associated with offering contingency management programs for patients despite evidence
that such treatment is highly effective for some patients, especially those with stimulant use
disorder.
Why Are Contingency Management Programs a Fraud and Abuse Risk?
As part of the CM Program, Medicare and Medicaid patients receive cash or in-kind
compensation in exchange for engaging in certain behaviors including substance use
disorder treatment therapies. The OIG has historically warned against offering or paying cash
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incentives to program beneficiaries and was therefore asked whether the digitally operated
CM Program violated the Anti-Kickback Statute and Beneficiary Inducement Civil Monetary
Penalty laws.
The Anti-Kickback Statute (AKS), 42 U.S.C. Section 1320a-7b(b), makes it a crime to
knowingly and willfully offer, pay, solicit, or receive any remuneration directly or indirectly to
induce or reward patient referrals or to generate business involving any item or service
reimbursable by a Federal health care program. When a provider offers, pays, solicits, or
receives unlawful remuneration, the provider violates the AKS. Remuneration includes
anything of value, such as cash, free rent, hotel stays, meals, and excessive compensation for
services.
The Beneficiary Inducements Civil Monetary Penalty Laws provides for the imposition of
civil monetary penalties against any person who offers or transfers remuneration to a
Medicare or Medicaid beneficiary that the person knows or should know is likely to influence
the beneficiary’s selection of a particular provider, practitioner, or supplier for the order or
receipt of any item or service for which payment may be made, in whole or in part, by
Medicare or a State health care program. 42 U.S.C. § 1320a7a(a)(5).
The OIG has issued repeated alerts against providers or suppliers giving gifts to beneficiaries
as such gifts might influence their choice of provider or service. New or amended safe
harbors finalized in 2020 protect certain patient engagement incentives but only when the
incentives are capped and associated with value-based payment arrangements, Accountable
Care Organization beneficiary incentive programs, or when the incentive is in the form of
limited local transportation services. Even the new safe harbors don’t protect cash, gift cards,
waivers or reductions in cost-sharing amounts and cap the in-kind benefits to $500 per
patient per year as part of any value-based-payment arrangement.
As part of the review of the CM Program, the OIG examined:
1) the fee arrangement between the digital CM Company and its customers for
appropriate safeguards and ‘fair market value’ compensation; and
2) the relationship between all participants and the beneficiaries receiving incentives
to determine overall program compliance.
Based on the specific facts of the digital CM Program for substance use disorder patients, the
OIG concluded that while the CM Program implicates the Anti-Kickback Statute and the
Beneficiary Inducement Civil Monetary Penalty laws and no regulatory safe harbor applies,
the specific arrangement as operated would not result in enforcement action.
Why Did the OIG Approve This Contingency Management Program?
The OIG highlights the following characteristics of the CM Program that drives the “won’t
impose administrative sanctions” opinion:
•

A digital company operates the CM Program: The CM Program is operated by
DynamicCare Health and uses smartphone and smart debit card technology to
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implement contingency management and administer the incentives for individuals.
DynamicCare Health is not enrolled in Medicare or Medicaid;
•

The digital company operating the CM Program contracts with “customers” at
fair market value: DynamicCare Health, Inc. contracts with treatment providers and
health plans to offer the CM Program to individuals who need substance use disorder
treatment and the fee is “fair market value” not based on volume or value of referrals;

•

The CM Program is protocol driven and evidenced based: The CM Program is
“evidence-based, protocol-driven and consistent with principles for the effective
treatment of substance use disorders published by the National Institute on Drug
Abuse (NIDA).” The OIG concluded that the CM Program incentives are not “an
inducement to seek, or a reward for having sought, a particular federally reimbursable
treatment.”

•

The CM Incentives are low value, capped and not related to reimbursable
services: The incentives are low value and administered entirely by the CM digital
company consistent with detailed protocols set forth in the opinion. Incentives are
typically $5 per successful test or achievement and are capped at $200/month and
$599/year. A substantial portion of the CM Program incentives are not associated
with federally payable services and the digital CM company is not an enrolled provider
or supplier.

•

Health care professionals and entities are minimally involved in the CM Program:
DynamicCare Health’s customer base is “varied” and many have no incentive to induce
patients to receive reimbursable services. In addition, the OIG noted that when
customers are professionals or entities that treat Medicare and Medicaid patients,
these customers are not administering the CM Program, although the incentives may
be tied to the patient attending treatment sessions which are verified via GPS for inperson visits or electronically for virtual visits. The fees paid by customers do not vary
based on the volume or value of any federally reimbursable services, and the CM
Program is protocol-driven and set by CM Program, not the customers.

While the OIG continues to be suspicious that cash and cash equivalent remuneration to
beneficiaries raises a substantial risk of fraud and abuse, the OIG confirmed it would not
impose administrative sanctions on the CM Program as operated by the DynamicCare Health.

SPECIFIC FACTS AND PROTOCOLS OF THE APPROVED CM PROGRAM
As always, the OIG limited its review and favorable opinion to the specific facts of the CM
Program. The facts and details below are quoted directly from the Advisory Opinion, pp 3-6
and therefore material to the opinion.
Enrollment
An individual may seek the CM Program’s services via referral from a customer or self-referral.
The CM Program certified that its enrollment team follows a formal protocol with training and
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ongoing supervision by licensed clinical supervisors. Pursuant to the protocol, the CM
Program obtains enrollment information from the following sources:
(i)
(ii)
(iii)
(iv)

the referrer, if available;
a structured interview of the individual;
an open-ended discussion with the individual; and
input from support persons, e.g., a significant other and family members, if
available.

The structured interview uses the American Society of Addiction Medicine Continuum Triage
tool, which CM Program certified various public entities (e.g., county health departments) use
to determine, among other things, whether the interviewee has a substance use disorder.
In particular, the tool prompts the enrollment specialist to obtain information that enables a
branching algorithm to determine if the interviewee:
(i)
(ii)
(iii)

has a substance use disorder;
requires treatment, and if so, for which priority substance(s); and
requires a specific level of care.

Type of Services
The enrollment specialist, under the guidance of a licensed clinical supervisor, determines the
type of services (e.g., alcohol, drug, or nicotine testing, or medication administration
reminders) and amount of services appropriate for each individual enrolled in the Program
(each, a “Member”). The frequency of any Member’s recovery coaching is determined by CM
Program’s algorithm using baseline Member data. Once the Member begins the Program, its
algorithm continuously varies the frequency of testing according to the Member’s
performance (e.g., results of substance testing or participation in recovery coaching), with
additional tests added “for cause” by the Member’s recovery coach.
The CM Program’s services are set according to an evidence-based, automated algorithm over
a 12-month period, which is divided into 3 phases of approximately 4 months each:
(i)
(ii)
(iii)

the anchor phase, during which the Member will have frequent substance
testing and active CM Incentives for achieving specified behavioral health goals
(e.g., a negative substance test);
the build phase, during which the substance testing frequency decreases and
CM incentives begin phasing out; and
the maintenance phase, during which the CM Program reinforces the
behavioral health goals through non-incentive community reinforcers, such as
employment and relationships.

The CM Program technology establishes the schedule of expected target health behavioral
events, objectively validates whether each expected event has occurred, and if it has,
promptly disburses the exact, protocol-specified CM incentive to the Member, using (where
appropriate) a progressive reinforcement schedule.
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The CM Program includes a wide variety of features that vary by Member, including, but not
limited to:
•
•
•
•
•
•
•
•

Automated appointment reminders, with both GPS (for in-person) and electronic
(for virtual) attendance verification;
Medication reminders and self-administration verification via self-video;
Saliva drug testing, breathalyzer alcohol testing, Smokerlyzer CO testing for
tobacco, and saliva cotinine testing for e-cigarettes, all verified via self-video;
Cognitive Behavioral Therapy (“CBT”), which includes 90 modules, on a variety of
topics, each 2-5 minutes in length, with effort validation through exercises,
comprehension questions, and detection of actual reading duration;
Various surveys and assessments;
Certified recovery coaching offered weekly via video link or telephone call plus
unlimited texting during business hours, with addiction specialist expert clinical
supervision;
Certified family partners for significant others and family members, with
community reinforcement and family training, which consists of video training in
an evidence based support model; and
Daily virtual support groups moderated by certified recovery coaches (for
Members) or certified family partners (for support persons).

Patient Incentives
The CM Program is digital and does not include any in-person elements. The CM Program’s
incentives, however, may be tied to certain services furnished in-person by another
provider—which could include a customer—such as attending a treatment session (which is
verified via GPS for in-person visits or electronically for virtual visits).
While most of the CM Program’s current customers are entities that do not bill Federal health
care programs, some current customers do bill, and other potential future customers may bill,
Federal health care programs for services that they provide (e.g., group therapy sessions).
The CM Program provides CM incentives via a smart debit card. While the smart debit card
looks like a typical debit card, the CM Program certified that it includes abuse and anti-relapse
protections (e.g., it cannot be used at bars, liquor stores, casinos, or certain other locations nor
can it be used to convert credit to cash at ATMs or gas stations).
The CM Program can monitor Members’ use of the smart debit cards, allowing coaches and
providers to be signaled of the possible need for intervention in the event of a blocked
purchase. As stated above, the CM Program furnishes members with CM Incentives for
achieving specified behavioral health goals.
The CM Program’s protocol allocates 70 percent of the potential CM incentives for verified,
consistent substance tests (i.e., consistent with medical expectations) and medication
adherence, 20 percent for treatment attendance, and 10 percent for self-guided CBT modules
and other features, such as follow-up self-assessments.
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The CM incentives are capped at $200.00 per month, with an annual maximum of $599.00 per
Member per year. Individual CM incentives typically are relatively small (e.g., $1.00-$3.00), but
a particular CM Incentive could be slightly larger if a member has a progressive reinforcement
schedule.
The CM Program certified that it is authorized by the customer for 1 month and then must be
reauthorized each subsequent month, for up to 12 months. The CM Program’s 2021 data (as
of September 2021) show that 86 percent of Members who start the CM Program are still
active in their third month.
Customer Payment Contracts
Typically, the CM Program contracts with customers that pay for the CM Program. Members
and their families also have the ability to self-refer and pay for the CM Program, in which case
the member or family member is the customer.
The CM Program receives fees from customers on: (i) a flat monthly basis per eligible, active
Member; or (ii) a pay-for-performance model, in which the CM Program is paid upon a
Member achieving certain agreed-upon targets for abstinence. In the pay-for-performance
model, Customers pay a lower flat rate per active Member but a substantially higher rate for
each Member who achieves clinical success in a given month.
CM Program certified that the aggregate fees are consistent with fair market value and do not
vary based on the volume or value of business generated under Federal health care
programs. Instead, fees vary based on the service configurations being purchased and the
intensity of behavioral targets that are planned for each member.
Fees include the costs of the application, any substance testing equipment that is shipped to
the member, test monitoring, medication self-administration monitoring, appointment
attendance monitoring, recovery coaching, and CM incentives. The fees also may vary based
on whether members are considered low-risk or high risk, and whether they are in treatment
or out of treatment.
CM incentives are held in reserve until the Member is verified by the system as having
successfully completed each expected behavioral health goal. CM Program detects Member
activity month-by-month; in a given month, if a member does not engage in using the
application, the member is detected by the system as “inactive” for the month. When a
member is inactive, the customer is not billed any fees and the unspent CM Incentive fees
continue to be held in reserve for the member.

CONCLUSION
The OIG Advisory Opinion offers hope to those seeking to support substance use disorder
patients with evidenced based contingency management or motivational incentive
programs. However, due to the risks of fraud and abuse, and the specific details of the
approved digital CM Program, any entity, provider or supplier seeking to offer a program to
patients should consult legal counsel.
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Please send questions or concerns to:
Lucy C. Hodder, JD
Director of Health Law and Policy
Professor of Law
UNH Franklin Pierce School of Law
Institute for Health Policy and Practice
Lucy.Hodder@unh.edu

This legal update should not be relied upon as legal advice.
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